JPRN-UMIN000033322招募中未知
The multicenter clinical trial to investigate the safety and efficacy of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysis - The feasibility study of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysis
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Hyperammonemia within 14 days before registration. 2) Peripheral sensory neuropathy Grade 2 (evaluated in CTCAE v 4.0) or more. 3) Oral administration of warfarin is necessary. 4) During peritoneal dialysis. 5) Cirrhosis (Child-Pugh B, C) 6) Symptoms that suspect encephalopathy such as gait disturbance and language disorder. 7) Patients refused to participate in this study. 8) The doctor judged inappropriate to register for this study
研究者
相似试验
招募中
不适用
The feasibility study of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysisEsophageal cancer, gastric cancer, small bowel cancer, colorectal cancerJPRN-jRCTs051190120Manabu Muto15
已完成
不适用
A multi-centre clinical trial evaluating the safety and functionality of a medical imaging device for tissue review during breast-conserving surgery.Cancer - BreastBreast CancerACTRN12623000205639OncoRes Medical Pty Ltd30
进行中（未招募）
不适用
An open multicenter clinical trial to evaluate the safety, tolerability and efficacy of Deferasirox (ICL670) in patients affected by Myelodysplastic syndrome and transfusional chronic hemosiderosis. - GIMEMA MDS 0306ow and intermediate I risk (IPSS score) Myelodysplastic syndrome and transfusion-induced hemosiderosis.MedDRA version: 9.1Level: LLTClassification code 10028533Term: Myelodysplastic syndromeEUCTR2006-006147-31-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
尚未招募
不适用
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
进行中（未招募）
不适用
A multi-center, open-label trial to investigate the safety and tolerability of intravenous SPM 927 as replacement for oral SPM 927 in subjects with partial seizures with or without secondary generalization.partial seizures with or without secondary generalizationMedDRA version: 6.0Level: LLTClassification code 10034089EUCTR2004-002322-22-DESCHWARZ BIOSCIENCES Inc.160